Expansion and evolution of cell death programmes

Nature Reviews Molecular Cell Biology

Volumn 9, Issue 5, 2008, Pages 378-390

  Degterev, Alexei ^a   Yuan, Junying ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL DEATH; CELL STRESS; CELL SURVIVAL; HUMAN; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; EVOLUTION; GENETICS; METABOLISM; PHYSIOLOGY;

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CARRIER PROTEIN; CASPASE; PROTEIN BCL 2; SIGNAL PEPTIDE;

ANIMALS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARRIER PROTEINS; CASPASES; CELL DEATH; EVOLUTION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NECROSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 42449123761     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2393     Document Type: Review

References (144)

1. Yuan, J. & Horvitz, H. R. A first insight into the molecular mechanisms of apoptosis. Cell 116, S53-S56 (2004). The authors provide in-depth insight into the discovery of the apoptotic machinery in C. elegans.
2. Clarke, P. G. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181, 195-213 (1990). This paper provides an early morphological analysis of developmental cell death and describes the existence of multiple forms of PCD.
3. Twomey, C. & McCarthy, J. V. Pathways of apoptosis and importance in development. J. Cell. Mol. Med. 9, 345-359 (2005).
4. Yoshida, H. et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94, 739-750 (1998).
5. Gu, Y. et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275, 206-209 (1997).
6. Wei, M. C. et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071 (2000).
7. McConkey, D. J. Biochemical determinants of apoptosis and necrosis. Toxicol. Lett. 99, 157-168 (1998).
8. Zong, W. X. & Thompson, C. B. Necrotic death as a cell fate. Genes Dev. 20, 1-15 (2006).
9. Horvitz, H. R., Shaham, S. & Hengartner, M. O. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol. 59, 377-385 (1994).
10. Conradt, B. & Xue, D. Programmed cell death. WormBook, 1-13 (2005).
11. Metzstein, M. M., Stanfield, G. M. & Horvitz, H. R. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. 14, 410-416 (1998).
12. Hofmann, E. R. et al. Caenorhabditis elegans HUS-1 is a DNA damage checkpoint protein required for genome stability and EGL-1-mediated apoptosis. Curr. Biol. 12, 1908-1918 (2002).
13. Tait, S. W. et al. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J. Cell Biol. 179, 1453-1466 (2007).
14. Konishi, Y., Lehtinen, M., Donovan, N. & Bonni, A. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol. Cell 9, 1005-1016 (2002).
15. Zha, J., Weiler, S., Oh, K. J., Wei, M. C. & Korsmeyer, S. J. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290, 1761-1765 (2000).
16. Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (1998).
17. Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nature Rev. Mol. Cell Biol. 9, 47-59 (2008).
18. Scorrano, L. & Korsmeyer, S. J. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem. Biophys. Res. Commun. 304, 437-444 (2003). This paper describes in detail the molecular mechanism of the key step in apoptosis where mitochondrial cytochrome c is released.
19. Willis, S. N. et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856-859 (2007). This paper presents evidence that suggests that anti-apoptotic BCL2 family members, rather than BAX and BAK, are the targets of BH3-only proteins.
20. Gogvadze, V., Orrenius, S. & Zhivotovsky, B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta 1757, 639-647 (2006).
21. Degterev, A., Boyce, M. & Yuan, J. A decade of caspases. Oncogene 22, 8543-8567 (2003).
22. Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S. & Peter, M. E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459 (1998).
23. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190 (2003). In this paper, upstream signalling events that lead to the activation of apoptosis are described.
24. Barnhart, B. C., Alappat, E. C. & Peter, M. E. The CD95 type I/type II model. Semin. Immunol. 15, 185-193 (2003). In this paper, distinct pathways (direct or mitochondria-mediated) of executioner caspase activation by death receptors are described in detail.
25. McStay, G. P., Salvesen, G. S. & Green, D. R. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 15, 322-331 (2007).
26. Sprick, M. R. et al. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J. 21, 4520-4530 (2002).
27. Su, H. et al. Requirement for caspase-8 in NF-kB activation by antigen receptor. Science 307, 1465-1468 (2005).
28. Lassus, P., Opitz-Araya, X. & Lazebnik, Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297, 1352-1354 (2002). In this paper, a specific role for caspase-2 in genotoxic stress-induced apoptosis is shown.
29. Hitomi, J. et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death. J. Cell Biol. 165, 347-356 (2004).
30. Nakagawa, T. et al. Caspase12 mediates endoplasmic-reticulum- specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98-103 (2000). This paper provides the first demonstration of the specific role of caspase-12 in ER stress response.
31. Zou, H., Li, Y., Liu, X. & Wang, X. An APAF-1cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556 (1999). The authors establish the existence of the caspase-9-activating apoptotosome complex.
32. Gao, Z., Shao, Y. & Jiang, X. Essential roles of the Bcl-2 family of proteins in caspase-2-induced apoptosis. J. Biol. Chem. 280, 38271-38275 (2005).
33. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999). This is one of the earliest papers establishing specific roles of a particular BH3-only factor, BIM, in response to specific upstream signals.
34. Yu, J. & Zhang, L. The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331, 851-588 (2005).
35. Schmelzle, T. et al. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc. Natl Acad. Sci. USA 104, 3787-3792 (2007).
36. Chen, L. et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17, 393-403 (2005). This paper demonstrates that selective interactions of pro- and anti-apoptotic BCL2 family members contribute to the regulation of the mitochondrial step in apoptosis.
37. Takai, Y. et al. Caspase-12 compensates for lack of caspase-2 and caspase-3 in female germ cells. Apoptosis 12, 791-800 (2007).
38. Troy, C. M. et al. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J. Neurosci. 21, 5007-5016 (2001).
39. Garcia-Calvo, M. et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 32608-32613 (1998).
40. Abraham, M. C., Lu, Y. & Shaham, S. A morphologically conserved nonapoptotic program promotes linker cell death in Caenorhabditis elegans. Dev. Cell 12, 73-86 (2007).
41. Oppenheim, R. W. et al. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci. 21, 4752-4760 (2001).
42. Yuan, J. Inducing autophagy harmlessly. Autophagy 4, 249-250 (2007).
43. Lee, C. Y. & Baehrecke, E. H. Steroid regulation of autophagic programmed cell death during development. Development 128, 1443-1455 (2001).
44. Berry, D. L. & Baehrecke, E. H. Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila. Cell 131, 1137-1148 (2007). This paper demonstrates that autophagic cell death is specifically activated during development under apoptosis-competent conditions.
45. Marino, G. et al. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J. Biol. Chem. 282, 18573-18583 (2007).
46. Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425-434 (2005).
47. Kuma, A. et al. The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036 (2004). This paper demonstrates the crucial role of autophagy in vivo in maintaining survival under nutrient-deprivation conditions.
48. Juhasz, G., Erdi, B., Sass, M. & Neufeld, T. P. Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev. 21, 3061-3066 (2007).
49. Espert, L. et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J. Clin. Invest. 116, 2161-2172 (2006).
50. Pattingre, S., Espert, L., Biard-Piechaczyk, M. & Codogno, P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323(2007).
51. Maiuri, M. C., Zalckvar, E., Kimchi, A. & Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Rev. Mol. Cell Biol. 8, 741-752 (2007).
52. Ullman, E. et al. Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress. Cell Death Differ. 15, 422-425 (2008).
53. Shimizu, S. et al. Role of Bcl-2 family proteins in a nonapoptotic programmed cell death dependent on autophagy genes. Nature Cell Biol. 6, 1221-1228 (2004).
54. Oberstein, A., Jeffrey, P. D. & Shi, Y. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J. Biol. Chem. 282, 13123-13132 (2007).
55. Pattingre, S. et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939 (2005). This paper presents evidence for the regulation of autophagy by the anti-apoptotic BCL2 family members, establishing convergent regulation of apoptosis and autophagy.
56. Tracy, K. & Macleod, K. F. Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy 3, 616-619 (2007).
57. Rashmi, R., Pillai, S. G., Vijayalingam, S., Ryerse, J. & Chinnadurai, G. BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene 27, 1366-1375 (2007).
58. Khwaja, A. & Tatton, L. Resistance to the cytotoxic effects of tumor necrosis factor a can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274, 36817-36823 (1999).
59. Matsumura, H. et al. Necrotic death pathway in Fas receptor. J. Cell Biol. 151, 1247-1256 (2000).
60. Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485 (1998).
61. Vercammen, D. et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188, 919-930 (1998).
62. Chan, F. K. et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278, 51613-51621 (2003).
63. Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chem. Biol. 1, 112-119 (2005). This paper describes a first-in-class potent and selective inhibitor of necroptosis.
64. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol. 1, 489-495 (2000). In this paper, the crucial role of RIP1 kinase activity in the activation of necroptosis is first demonstrated.
65. Kawahara, A., Ohsawa, Y., Matsumura, H., Uchiyama, Y. & Nagata, S. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143, 1353-1360 (1998). This paper is one of the initial reports showing induction of necrotic death by death-domain receptor signals.
66. Festjens, N., Vanden Berghe, T. & Vandenabeele, P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim. Biophys. Acta 1757, 1371-1387 (2006). This paper provides an in-depth analysis of the signalling and execution pathways of regulated necrosis.
67. Zheng, L. et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol. Cell Biol. 26, 3505-3513 (2006). This paper shows that apoptotic and necroptotic signalling pathways diverge at the level of the death-domain receptor.
68. Wang, K. et al. Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5. Bioorg. Med. Chem. Lett. 17, 1455-1465 (2007).
69. Jagtap, P. G. et al. Structure-activity relationship study of tricyclic necroptosis inhibitors. J. Med. Chem. 50, 1886-1895 (2007).
70. Teng, X. et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg. Med. Chem. Lett. 15, 5039-5044 (2005).
71. Temkin, V., Huang, Q., Liu, H., Osada, H. & Pope, R. M. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol. Cell Biol. 26, 2215-2225 (2006).
72. Lim, S. Y., Davidson, S. M., Mocanu, M. M., Yellon, D. M. & Smith, C. C. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc. Drugs Ther. 21, 467-469 (2007).
73. Suzuki, S. et al. Nur77 as a survival factor in tumor necrosis factor signaling. Proc. Natl Acad. Sci. USA 100, 8276-8280 (2003).
74. Jagtap, P. & Szabo, C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nature Rev. Drug Discov. 4, 421-440 (2005).
75. Oei, S. L., Keil, C. & Ziegler, M. Poly(ADP-ribosylation) and genomic stability. Biochem. Cell Biol. 83, 263-269 (2005).
76. Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q. & Thompson, C. B. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18, 1272-1282 (2004). This paper establishes the existence of the 'death by energy collapse' mechanism of PARP-1-mediated cell death.
77. Ditsworth, D., Zong, W. X. & Thompson, C. B. Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus. J. Biol. Chem. 282, 17845-17854 (2007) .
78. Andrabi, S. A. et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl Acad. Sci. USA 103, 18308-18313 (2006).
79. Yu, S. W. et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl Acad. Sci. USA 103, 18314-18319 (2006). This paper describes the mechanism of the PARP1-AIF cell death.
80. Xu, Y., Huang, S., Liu, Z. G. & Han, J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J. Biol. Chem. 281, 8788-8795 (2006).
81. Ellis, H. M. & Horvitz, H. R. Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817-829 (1986).
82. Aballay, A. & Ausubel, F. M. Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl Acad. Sci. USA 98, 2735-2739 (2001).
83. Martinon, F., Gaide, O., Petrilli, V., Mayor, A. & Tschopp, J. NALP inflammasomes: a central role in innate immunity. Semin. Immunopathol. 29, 213-229 (2007). This paper provides an extensive review of the mechanism of action and regulation of mammalian inflammasomes.
84. Martinon, F. & Tschopp, J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26, 447-454 (2005).
85. Ting, J. P., Kastner, D. L. & Hoffman, H. M. CATERPILLERs, pyrin and hereditary immunological disorders. Nature Rev. Immunol. 6, 183-195 (2006).
86. Srinivasula, S. M. et al. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277, 21119-21122 (2002).
87. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426 (2002). This paper provides an initial report demonstrating the existance of the caspase-1 activating inflammasome complex.
88. Bruey, J. M. et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129, 45-56 (2007). This paper presents evidence that inflammasome activity is inhibited by BCL2 family members.
89. Petrilli, V., Dostert, C., Muruve, D. A. & Tschopp, J. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19, 615-622 (2007).
90. Jones, J. D. & Dangl, J. L. The plant immune system. Nature 444, 323-329 (2006).
91. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
92. Faustin, B. et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25, 713-724 (2007).
93. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nature Immunol. 7, 576-582 (2006).
94. Miao, E. A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nature Immunol. 7, 569-575 (2006). References 93 and 94 establish that IPAF inflammasomes can sense intracellular PAMP signals.
95. Shen, Q. H. et al. Nuclear activity of MLA immune receptors links isolate-specific and basal disease-resistance responses. Science 315, 1098-1103 (2007).
96. Woltering, E. J. Death proteases come alive. Trends Plant Sci. 9, 469-472 (2004).
97. Vercammen, D., Declercq, W., Vandenabeele, P. & Van Breusegem, F. Are metacaspases caspases? J. Cell Biol. 179, 375-380 (2007).
98. Schmid, D. & Munz, C. Innate and adaptive immunity through autophagy. Immunity 27, 11-21 (2007). Reference 98 provides a detailed overview of the role of autophagy in the immune regulation.
99. Liang, X. H. et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J. Virol. 72, 8586-8596 (1998).
100. Nakagawa, I. et al. Autophagy defends cells against invading group A Streptococcus. Science 306, 1037-1040 (2004). This paper presents evidence that the activation of autophagy can serve a host defence function.
101. Py, B. F., Lipinski, M. M. & Yuan, J. Autophagy limits Listeria monocytogenes intracellular growth in the early phase of primary infection. Autophagy 3, 117-125 (2007).
102. Sanjuan, M. A. et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450, 1253-1257 (2007).
103. Xu, Y. et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27, 135-144 (2007).
104. Inbal, B., Bialik, S., Sabanay, I., Shani, G. & Kimchi, A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol. 157, 455-468 (2002).
105. Meylan, E. & Tschopp, J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 30, 151-159 (2005). A detailed review that discusses the structure and function of the RIP kinase family.
106. Cusson-Hermance, N., Khurana, S., Lee, T. H., Fitzgerald, K. A. & Kelliher, M. A. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem. 280, 36560-36566 (2005).
107. Meylan, E. et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nature Immunol. 5, 503-507 (2004).
108. Balachandran, S., Thomas, E. & Barber, G. N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432, 401-405 (2004).
109. Georgel, P. et al. Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis. Dev. Cell 1, 503-514 (2001).
110. Petersen, S. L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445-456 (2007).
111. Vanden Berghe, T. et al. Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal 18, 328-335 (2006).
112. Korkina, O. & Degterev, A. in Wiley Encyclopedia of Chemical Biology (ed. Begley, T. P.) (John Wiley and Sons, Ltd, 2008).
113. Shimizu, S., Konishi, A., Kodama, T. & Tsujimoto, Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl Acad. Sci. USA 97, 3100-3105 (2000).
114. Cheng, E. H. et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966-1968 (1997).
115. Acehan, D. et al. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423-432 (2002). This is the first paper to provide structural insight into the functioning of the apoptosome.
116. Park, H. H. et al. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128, 533-546 (2007).
117. Mizushima, N. Autophagy: process and function. Genes Dev. 21, 2861-2873 (2007). This is an in-depth review that describes recent progress in understanding autophagic regulation.
118. Yu, L. et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502 (2004). This paper demonstrates activation of autophagic cell death resulting from caspase inhibition.
119. Kim, Y. S., Morgan, M. J., Choksi, S. & Liu, Z. G. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell 26, 675-687 (2007).
120. Schulze-Osthoff, K. et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267, 5317-5323 (1992).
121. Festjens, N. et al. Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death Differ. 13, 166-169 (2006).
122. Thon, L. et al. Ceramide mediates caspase-independent programmed cell death. FASEB. J. 19, 1945-1956 (2005).
123. Ame, J. C., Spenlehauer, C. & de Murcia, G. The PARP superfamily. Bioessays 26, 882-893 (2004). This is a detailed review of the structure and function of PARP family members.
124. Vahsen, N. et al. AIF deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679-4689 (2004). In this report, the metabolic function of AIF in the regulating activity of mitochondrial complex I is established.
125. Zhu, H. et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 117, 1782-1793 (2007).
126. Matsui, Y. et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100, 914-922 (2007).
127. Amaravadi, R. K. et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117, 326-336 (2007). This paper demonstrates that the induction of autophagy in cancer cells in vivo enhances tumour growth through the inhibition of apoptosis.
128. Edinger, A. L. & Thompson, C. B. Defective autophagy leads to cancer. Cancer Cell 4, 422-424 (2003).
129. Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64 (2006). This paper demonstrates the plasticity of cancer cell death activation under hypoxic conditions by demonstrating the activation of apoptosis, autophagy and necrosis that is dependent on the expression of specific protein factors in the cell.
130. Smith, C. C. et al. Necrostatin: a potentially novel cardioprotective agent? Cardiovasc. Drugs Ther. 21, 227-233 (2007).
131. de la Lastra, C. A., Villegas, I. & Sanchez-Fidalgo, S. Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications. Curr. Pharm. Des. 13, 933-962 (2007).
132. Horvath, E. M. & Szabo, C. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update. Drug News Perspect. 20, 171-181 (2007).
133. Kauppinen, T. M. & Swanson, R. A. The role of poly(ADP-ribose) polymerase-1 in CNS disease. Neuroscience 145, 1267-1272 (2007).
134. Zaremba, T. & Curtin, N. J. PARP inhibitor development for systemic cancer targeting. Anticancer Agents Med. Chem. 7, 515-523 (2007).
135. Martinon, F. & Tschopp, J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14, 10-22 (2007).
136. Muppidi, J. R., Tschopp, J. & Siegel, R. M. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21, 461-465 (2004).
137. O'Donnell, M. A., Legarda-Addison, D., Skountzos, P., Yeh, W. C. & Ting, A. T. Ubiquitination of RIP1 regulates an NF-κB-independent cell-death switch in TNF signaling. Curr. Biol. 17, 418-424 (2007).
138. Hong, Q. et al. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-κB, JNK1, p53 and WOX1 during stress response. BMC Mol. Biol. 8, 50 (2007).
139. Takahashi, R. et al. Focal adhesion kinase determines the fate of death or survival of cells in response to TNFα in the presence of actinomycin D. Biochim. Biophys. Acta 1770, 518-526 (2007).
140. Leist, M. et al. Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp. Cell Res. 249, 396-403 (1999).
141. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486 (1997). This paper introduces the idea that intrinsic differences in cellular energy levels might have a key role in the selection of a cell's form of death: either apoptotic or necrotic.
142. Volbracht, C., Leist, M. & Nicotera, P. ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation. Mol. Med. 5, 477-489 (1999).
143. Nicotera, P., Leist, M., Fava, E., Berliocchi, L. & Volbracht, C. Energy requirement for caspase activation and neuronal cell death. Brain Pathol. 10, 276-282 (2000).
144. Dimmeler, S., Haendeler, J., Sause, A. & Zeiher, A. M. Nitric oxide inhibits APO-1/Fas-mediated cell death. Cell Growth Differ. 9, 415-422 (1998).